CD79A and cancer: These up-regulated genes in the resistant group were significantly associated with processes like the intestinal immune network for IgA production, HIF-1 signaling pathway, p53 signaling pathway, pathways in cancer, and fructose and mannose metabolism, along with various other metabolic pathways.